Browsing Tag
F2G Ltd.
1 post
F2G and Shionogi move closer to commercializing novel oral antifungal after pivotal trial results
Shionogi shares gain as olorofim's Phase 3 success advances its F2G partnership. Explore the $480M deal, FDA plans and market potential.